UroGen Pharma Ltd.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-20.0M | $-1.9M | $-12.7M |
| Depreciation & Amortization | $200.0K | $200.0K | — |
| Depreciation | $207.0K | $213.0K | $113.0K |
| Amortization | — | — | — |
| Stock-Based Compensation | $6.3M | $2.0M | $449.0K |
| Net Cash from Operating Activities | $-9.6M | $4.2M | $-7.2M |
| Investing Activities | |||
| Capital Expenditures | $271.0K | $695.0K | $301.0K |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $-36.3M | $-719.0K | $-301.0K |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $61.6M | $-9.0K | $21.6M |
| Net Change in Cash | $15.6M | $3.4M | $14.1M |
| Free Cash Flow | $-9.8M | $3.5M | $-7.5M |